Key Laboratory of Viral Hepatitis of Hunan Province, Xiangya Hospital, Central South University, Xiangya Road 87, Kaifu District, Changsha, 410008, China.
Institute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
J Nanobiotechnology. 2022 Feb 14;20(1):78. doi: 10.1186/s12951-022-01275-2.
BACKGROUND: Despite novel advances in screening, targeting and immunotherapies, early diagnosis and satisfactory treatments against hepatocellular carcinoma (HCC) remain formidable challenges. Given the unique advantages, carbon quantum dots (CQDs) become a smart theranostic nanomaterial for cancer diagnosis and therapy. RESULTS: In this work, a type of bio-friendly CQDs, trichrome-tryptophan-sorbitol CQDs (TC-WS-CQDs), is synthesized from natural biocompatible tryptophan via the one-pot hydrothermal method. Compared with normal hepatocytes, a much stronger green fluorescence is detected in HCC cells, indicating the ability of TC-WS-CQDs to target HCC cells. Furthermore, green-emitting TC-WS-CQDs generate large amounts of reactive oxygen species (ROS), leading to autophagy of HCC cells. Additionally, the green-emitting TC-WS-CQDs perform significant tumor inhibition by inducing autophagy via p53-AMPK pathway in vitro and in vivo studies with almost no systemic toxicity. CONCLUSIONS: The results may highlight a promising anticancer nanotheranostic strategy with integration of diagnosis, targeting, and therapy.
背景:尽管在筛查、靶向和免疫治疗方面取得了新的进展,但肝癌(HCC)的早期诊断和满意治疗仍然是巨大的挑战。鉴于其独特的优势,碳量子点(CQDs)成为癌症诊断和治疗的一种智能治疗纳米材料。
结果:在这项工作中,从天然生物相容性色氨酸通过一锅水热法合成了一种生物友好型 CQDs,三原色-色氨酸-山梨醇 CQDs(TC-WS-CQDs)。与正常肝细胞相比,在 HCC 细胞中检测到更强的绿色荧光,表明 TC-WS-CQDs 能够靶向 HCC 细胞。此外,发绿光的 TC-WS-CQDs 产生大量的活性氧(ROS),导致 HCC 细胞自噬。此外,发绿光的 TC-WS-CQDs 通过 p53-AMPK 通路在体外和体内研究中诱导自噬,对肿瘤具有显著的抑制作用,几乎没有全身毒性。
结论:这些结果可能突出了一种有前途的癌症纳米治疗策略,该策略将诊断、靶向和治疗相结合。
J Nanobiotechnology. 2022-2-14
J Biomed Mater Res B Appl Biomater. 2020-5
Bioconjug Chem. 2021-2-17
Colloids Surf B Biointerfaces. 2018-6-12
Spectrochim Acta A Mol Biomol Spectrosc. 2017-10-21
Int J Nanomedicine. 2025-5-31
Clin Mol Hepatol. 2025-1
Discov Nano. 2024-8-5
Nanomaterials (Basel). 2024-6-25
Bioact Mater. 2023-11-15
Cancers (Basel). 2021-4-21
Nat Commun. 2021-2-5
Biosensors (Basel). 2020-6-17
Theranostics. 2020